Developments include positive clinical results for an mRNA vaccine, a major design partnership between Google and Marvell, and macroeconomic shifts regarding currency and Bitcoin.

The entities involved

• Moderna →

  American biotechnology company

  • Moderna and Merck announced the successful outcome of their Phase 3 combined treatment trials involving a new cancer vaccine and Keytruda.Sun 12:39
  • Merck and Moderna funded an Australian-led clinical trial involving the University of Sydney.Sat 22:35
• Google →

  American multinational technology company, a subsidiary of Alphabet Inc.

  • Google's data center projects in Finland are being halted pending environmental assessments.Sun 22:06
  • Apple struggled with AI, forcing an alignment with Alphabet, while John Ternus is expected to reinvigorate tech stock growth.Sun 20:14
• U.S. Treasury →

  mine in Sierra County, New Mexico, United States of America

  • The Office of the Comptroller of the Currency and U.S. Treasury fined Bank of America for reporting and compliance failures.Sun 17:44
  • Donald Trump unveiled new accounts involving U.S. Treasury deposits, while the NYSE did not respond to Treasury-related requests.Sat 16:07

Related events

• Moderna and Merck announced a partnership on their mRNA cancer vaccine trial, leading to analyst rating hikes.Aug 25